3812 results for «2024»
3812 results
Focus on simulation - PCR London Valves 2024
Francesco Maisano and Pamela Gatto highlight the simulation-based learning approach at PCR London Valves. This educational journey begins with observing experts, followed by hands-on training, fostering discussions, idea exchange, and device testing before real interventions. The structured programme, complete with a "passport," offers specialized tracks for...

"My Take on OCT Trials" by Davide Capodanno: CRT 2024
19 Mar 2024
View a series of commented slides illustrating major takeaways from a network meta-analysis of Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention. These slides and comments were originally shared via Twitter upon the occasion of the 2024 Cardiovascular Research...

Author

Focus on the PCR Tricuspid Focus Group - PCR London Valves 2024
Julien Dreyfus and Fabien Praz discuss the mission of the PCR Tricuspid Focus Group, aimed at consolidating knowledge on tricuspid valve regurgitation. The main goal is to define future directions and establish best practices to ensure optimal patient care.
This interview was filmed at PCR London Valves...

Focus on Fundamentals in TAVI and mitral - PCR London Valves 2024
Christopher Cook interviews Nicole Karam about the Fundamentals Course, a key component of the PCR London Valves programme that continues to expand each year. Designed for beginners in TAVI or mitral interventions, the course guides participants through every step of a procedure, starting with the basics...

Abstract Book - PCR London Valves 2024
24 Nov 2024
Filter and access all abstracts successfully submitted to the Course this year!

Are you an EAPCI Member?

EuroPCR 2023 – FAQ about signing up

Meet the Team

Spotlight on a selection of top Late-breaking Trials presented at PCR London Valves 2024
24 Nov 2024
View a snapshot of the results of these 3 trials presented in London: TRISCEND II, COMPARE-TAVI cohort B and the 30-day Outcomes of the TF J-VALVE for Chronic AR

EuroPCR 2024 – Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...

EuroPCR 2024 – Short-term data from NOTION-2: TAVR versus SAVI for younger patients with aortic stenosis
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice....

REC-CAGEFREE II, NOTION-2, LANDMARK: Three major late-breaking trials presented at EuroPCR 2024
15 May 2024
The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice.

EuroPCR 2024 – One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...

MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.
15 May 2024

EuroPCR 2024: Late-breaking data demonstrate significant clinical advantage of Elixir Medical’s DynamX bioadaptor over standard-of-care drug-eluting stent at two years
14 May 2024

EuroPCR 2024: Elixir Medical’s late-breaking 12-month data demonstrate significant improvement in safety and effectiveness of world’s first site-specific antithrombotic therapeutic compared to DES
14 May 2024

EuroPCR 2024: Primary outcomes from PINNACLE I clinical trial establish safety and effectiveness of Elixir Medical’s Hertz Contact Intravascular Lithotripsy System for calcium fragmentation in moderate to severe calcified coronary artery lesions
16 May 2024

Europa Group's General Terms and Conditions of Sale
12 Apr 2024
Ref 02P - Updated June 2024

Mitral sessions from EuroPCR 2025: Abbott
19 Jun 2025
Watch these recordings from EuroPCR 2025 and PCR London Valves 2024 on Mitral.

The Jon DeHaan Foundation rewards another innovative idea!
15 May 2024
The competition for the Jon DeHaan Foundation Award was tough at PCR lnnovators Day 2024, but the A-FLUX Reducer System was crowned the winner.
